Literature DB >> 28116799

In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish.

Celinda M Kofron1, Ulrike Mende1.   

Abstract

The heart is a complex pluricellular organ composed of cardiomyocytes and non-myocytes including fibroblasts, endothelial cells and immune cells. Myocytes are responsible for electrical conduction and contractile force generation, while the other cell types are responsible for matrix deposition, vascularization, and injury response. Myocytes and non-myocytes are known to communicate and exert mutual regulatory effects. In concert, they determine the structural, electrical and mechanical characteristics in the healthy and remodelled myocardium. Dynamic crosstalk between myocytes and non-myocytes plays a crucial role in stress/injury-induced hypertrophy and fibrosis development that can ultimately lead to heart failure and arrhythmias. Investigations of heterocellular communication in the myocardium are hampered by the intricate interspersion of the different cell types and the complexity of the tissue architecture. In vitro models have facilitated investigations of cardiac cells in a direct and controllable manner and have provided important functional and mechanistic insights. However, these cultures often lack regulatory input from the other cell types as well as additional topographical, electrical, mechanical and biochemical cues from the cardiac microenvironment that all contribute to modulating cell differentiation, maturation, alignment, function and survival. Advancements in the development of more complex pluricellular physiological platforms that incorporate diverse cues from the myocardial microenvironment are expected to lead to more physiologically relevant cardiac tissue-like in vitro models for mechanistic biological research, disease modelling, therapeutic target identification, drug testing and regeneration.
© 2017 The Authors. The Journal of Physiology © 2017 The Physiological Society.

Entities:  

Keywords:  2D culture; 3D culture; cardiac fibroblasts; cardiac myocytes; crosstalk; endothelial cells; myocardium; tissue engineering

Mesh:

Substances:

Year:  2017        PMID: 28116799      PMCID: PMC5471366          DOI: 10.1113/JP273100

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  155 in total

1.  Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes.

Authors:  Hoi Ting H Au; Irene Cheng; Mohammad F Chowdhury; Milica Radisic
Journal:  Biomaterials       Date:  2007-07-02       Impact factor: 12.479

Review 2.  Animal models of heart failure: a scientific statement from the American Heart Association.

Authors:  Steven R Houser; Kenneth B Margulies; Anne M Murphy; Francis G Spinale; Gary S Francis; Sumanth D Prabhu; Howard A Rockman; David A Kass; Jeffery D Molkentin; Mark A Sussman; Walter J Koch; Walter Koch
Journal:  Circ Res       Date:  2012-05-17       Impact factor: 17.367

Review 3.  Engineering cell alignment in vitro.

Authors:  Yuhui Li; Guoyou Huang; Xiaohui Zhang; Lin Wang; Yanan Du; Tian Jian Lu; Feng Xu
Journal:  Biotechnol Adv       Date:  2013-11-22       Impact factor: 14.227

4.  Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts.

Authors:  Hidekazu Sekine; Tatsuya Shimizu; Kyoko Hobo; Sachiko Sekiya; Joseph Yang; Masayuki Yamato; Hiromi Kurosawa; Eiji Kobayashi; Teruo Okano
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

5.  Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers.

Authors:  Susan A Thompson; Craig R Copeland; Daniel H Reich; Leslie Tung
Journal:  Circulation       Date:  2011-05-02       Impact factor: 29.690

6.  Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating.

Authors:  Adam J Engler; Christine Carag-Krieger; Colin P Johnson; Matthew Raab; Hsin-Yao Tang; David W Speicher; Joseph W Sanger; Jean M Sanger; Dennis E Discher
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

Review 7.  Human engineered heart tissue as a model system for drug testing.

Authors:  Alexandra Eder; Ingra Vollert; Arne Hansen; Thomas Eschenhagen
Journal:  Adv Drug Deliv Rev       Date:  2015-05-27       Impact factor: 15.470

Review 8.  Heading in the Right Direction: Understanding Cellular Orientation Responses to Complex Biophysical Environments.

Authors:  Chiara Tamiello; Antonetta B C Buskermolen; Frank P T Baaijens; Jos L V Broers; Carlijn V C Bouten
Journal:  Cell Mol Bioeng       Date:  2015-11-02       Impact factor: 2.321

Review 9.  Biology of the cardiac myocyte in heart disease.

Authors:  Angela K Peter; Maureen A Bjerke; Leslie A Leinwand
Journal:  Mol Biol Cell       Date:  2016-07-15       Impact factor: 4.138

10.  The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells.

Authors:  Christopher Rao; Themistoklis Prodromakis; Ljudmila Kolker; Umar A R Chaudhry; Tatiana Trantidou; Arun Sridhar; Claire Weekes; Patrizia Camelliti; Sian E Harding; Ara Darzi; Magdi H Yacoub; Thanos Athanasiou; Cesare M Terracciano
Journal:  Biomaterials       Date:  2012-12-20       Impact factor: 12.479

View more
  16 in total

1.  Gq-activated fibroblasts induce cardiomyocyte action potential prolongation and automaticity in a three-dimensional microtissue environment.

Authors:  C M Kofron; T Y Kim; M E King; A Xie; F Feng; E Park; Z Qu; B-R Choi; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

2.  Cardiac regulatory mechanisms: new concepts and challenges.

Authors:  Björn C Knollmann
Journal:  J Physiol       Date:  2017-06-15       Impact factor: 5.182

3.  Arrhythmia Assessment in Heterotypic Human Cardiac Myocyte-Fibroblast Microtissues.

Authors:  Celinda M Kofron; Bum-Rak Choi; Kareen L K Coulombe
Journal:  Methods Mol Biol       Date:  2022

4.  Network-based predictions of in vivo cardiac hypertrophy.

Authors:  Deborah U Frank; Matthew D Sutcliffe; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2018-07-17       Impact factor: 5.000

Review 5.  Regulators of cardiac fibroblast cell state.

Authors:  Ross Bretherton; Darrian Bugg; Emily Olszewski; Jennifer Davis
Journal:  Matrix Biol       Date:  2020-05-19       Impact factor: 11.583

6.  A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues.

Authors:  Celinda M Kofron; Tae Yun Kim; Bum-Rak Choi; Kareen L K Coulombe; Fabiola Munarin; Arvin H Soepriatna; Rajeev J Kant; Ulrike Mende
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

Review 7.  Vascularisation of pluripotent stem cell-derived myocardium: biomechanical insights for physiological relevance in cardiac tissue engineering.

Authors:  Oisín King; Ilona Sunyovszki; Cesare M Terracciano
Journal:  Pflugers Arch       Date:  2021-04-14       Impact factor: 3.657

8.  Characterization and Validation of a Human 3D Cardiac Microtissue for the Assessment of Changes in Cardiac Pathology.

Authors:  Caroline R Archer; Rebecca Sargeant; Jayati Basak; James Pilling; Jennifer R Barnes; Amy Pointon
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

Review 9.  Endothelial cell-cardiomyocyte crosstalk in heart development and disease.

Authors:  Andrea Colliva; Luca Braga; Mauro Giacca; Serena Zacchigna
Journal:  J Physiol       Date:  2019-03-27       Impact factor: 5.182

10.  Directed fusion of cardiac spheroids into larger heterocellular microtissues enables investigation of cardiac action potential propagation via cardiac fibroblasts.

Authors:  Tae Yun Kim; Celinda M Kofron; Michelle E King; Alexander R Markes; Amenawon O Okundaye; Zhilin Qu; Ulrike Mende; Bum-Rak Choi
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.